TIMP-3 deficiency accelerates cardiac remodeling after myocardial infarction.
暂无分享,去创建一个
Hai Tian | Ren-Ke Li | S. Fazel | R. Weisel | Ren-Ke Li | P. Fedak | S. Altamentova | Richard D Weisel | Svetlana Altamentova | Massimo Cimini | Paul W M Fedak | Shafie Fazel | Ming-Li Huang | M. Cimini | Hai Tian | Ming-Li Huang
[1] R. Schulz,et al. Imbalance Between Tissue Inhibitor of Metalloproteinase-4 and Matrix Metalloproteinases During Acute Myoctardial Ischemia-Reperfusion Injury , 2003 .
[2] Y. Sun,et al. Differential expression of tissue inhibitors of metalloproteinases in the failing human heart. , 1998, Circulation.
[3] R. Khokha,et al. Lack of tissue inhibitor of metalloproteinases-3 results in an enhanced inflammatory response in antigen-induced arthritis. , 2005, The American journal of pathology.
[4] P. Libby,et al. Targeted deletion of matrix metalloproteinase-9 attenuates left ventricular enlargement and collagen accumulation after experimental myocardial infarction. , 2000, The Journal of clinical investigation.
[5] B. Strauss,et al. Vascular matrix remodeling in patients with bicuspid aortic valve malformations: implications for aortic dilatation. , 2003, The Journal of thoracic and cardiovascular surgery.
[6] Richard T. Lee,et al. Selective Matrix Metalloproteinase Inhibition Reduces Left Ventricular Remodeling but Does Not Inhibit Angiogenesis After Myocardial Infarction , 2002, Circulation.
[7] R. Visse,et al. Matrix Metalloproteinases Regulation and Dysregulation in the Failing Heart , 2002 .
[8] B. Fingleton,et al. Abnormal TNF activity in Timp3−/− mice leads to chronic hepatic inflammation and failure of liver regeneration , 2004, Nature Genetics.
[9] M. Zile,et al. Accelerated LV remodeling after myocardial infarction in TIMP-1-deficient mice: effects of exogenous MMP inhibition. , 2005, American journal of physiology. Heart and circulatory physiology.
[10] J. S. Janicki,et al. Inadequate collagen tethers in dilated cardiopathy. , 1988, American heart journal.
[11] W. Frederiks,et al. In Situ Localization of Gelatinolytic Activity in the Extracellular Matrix of Metastases of Colon Cancer in Rat Liver Using Quenched Fluorogenic DQ-gelatin , 2003, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.
[12] B. McGowan,et al. Tumor Necrosis Factor Receptors 1 and 2 Differentially Regulate Survival, Cardiac Dysfunction, and Remodeling in Transgenic Mice With Tumor Necrosis Factor-&agr;–Induced Cardiomyopathy , 2004 .
[13] R. Khokha,et al. TIMP-3 Deficiency Leads to Dilated Cardiomyopathy , 2004, Circulation.
[14] B. Strauss,et al. Matrix remodeling in experimental and human heart failure: a possible regulatory role for TIMP-3. , 2003, American journal of physiology. Heart and circulatory physiology.
[15] E. Creemers,et al. Deficiency of TIMP-1 exacerbates LV remodeling after myocardial infarction in mice. , 2003, American journal of physiology. Heart and circulatory physiology.
[16] S. Fazel,et al. Cell transplantation preserves cardiac function after infarction by infarct stabilization: augmentation by stem cell factor. , 2005, The Journal of thoracic and cardiovascular surgery.
[17] M. Satoh,et al. Tumor Necrosis Factor-α–Converting Enzyme and Tumor Necrosis Factor-α in Human Dilated Cardiomyopathy , 1999 .
[18] A. Baker,et al. Divergent effects of tissue inhibitor of metalloproteinase-1, -2, or -3 overexpression on rat vascular smooth muscle cell invasion, proliferation, and death in vitro. TIMP-3 promotes apoptosis. , 1998, The Journal of clinical investigation.
[19] R. Khokha,et al. Combination of Tumor Necrosis Factor-α Ablation and Matrix Metalloproteinase Inhibition Prevents Heart Failure After Pressure Overload in Tissue Inhibitor of Metalloproteinase-3 Knock-Out Mice , 2005, Circulation research.
[20] N. Doll,et al. Regression of Left Ventricular Hypertrophy After Surgical Therapy for Aortic Stenosis Is Associated With Changes in Extracellular Matrix Gene Expression , 2001, Circulation.
[21] R. Visse,et al. This Review Is Part of a Thematic Series on Matrix Metalloproteinases, Which Includes the following Articles: Matrix Metalloproteinase Inhibition after Myocardial Infarction: a New Approach to Prevent Heart Failure? Matrix Metalloproteinases in Vascular Remodeling and Atherogenesis: the Good, the Ba , 2022 .
[22] C. Murry,et al. Myofibroblast and endothelial cell proliferation during murine myocardial infarct repair. , 2003, The American journal of pathology.
[23] L. Claesson‐Welsh,et al. A novel function for tissue inhibitor of metalloproteinases-3 (TIMP3): inhibition of angiogenesis by blockage of VEGF binding to VEGF receptor-2 , 2003, Nature Medicine.
[24] B. Bozkurt,et al. Tumor necrosis factor-alpha and myocardial remodeling in progression of heart failure: a current perspective. , 2002, Cardiovascular research.
[25] F. Gao,et al. Heterogeneous effects of tissue inhibitors of matrix metalloproteinases on cardiac fibroblasts. , 2005, American journal of physiology. Heart and circulatory physiology.
[26] T. Mak,et al. Spontaneous air space enlargement in the lungs of mice lacking tissue inhibitor of metalloproteinases-3 (TIMP-3). , 2001, The Journal of clinical investigation.
[27] J. H. Dierendonck,et al. A new method to detect apoptosis in paraffin sections: in situ end-labeling of fragmented DNA. , 1993, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.
[28] J. Weitzman,et al. Examining the relationship between the gelatinolytic balance and the invasive capacity of endothelial cells. , 1999, Journal of cell science.
[29] M. Zile,et al. Changes in extracellular collagen matrix alter myocardial systolic performance. , 2003, American journal of physiology. Heart and circulatory physiology.